Search details
1.
Acalabrutinib, venetoclax and obinutuzumab in relapsed CLL: Final efficacy and ctDNA analysis of the CLL2-BAAG trial.
Blood
; 2024 Apr 15.
Article
in English
| MEDLINE | ID: mdl-38620072
2.
Noninvasive minimal residual disease assessment in relapsed/refractory large B-cell lymphoma using digital droplet PCR.
Eur J Haematol
; 112(6): 957-963, 2024 Jun.
Article
in English
| MEDLINE | ID: mdl-38369814
Results
1 -
2
de 2
1
Next >
>>